Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck promotes Kenneth Frazier to CEO, succeeding Richard Clark

This article was originally published in Scrip

Executive Summary

In a move that was widely expected, Merck has appointed Kenneth Frazier, its president, to the additional role of CEO effective 1 January 2011, succeeding Richard Clark.

Merck's in-coming CEO, Kenneth Frazier

Mr Clark, who has served as Merck's CEO since 2005, will continue as chairman of the board. He will turn 65 next year, the mandatory company CEO retirement age.

Mr Frazier's promotion, which also includes a position on the board, had been expected after the company named him president in April this year.

Mr Frazier has since focused on improving the effectiveness of the company's three largest divisions – Global Human Health (pharmaceutical and vaccine sales and marketing), Merck Research Laboratories (R&D), and Merck Manufacturing Division (manufacturing and supply) – and their post-merger integration.

Mr Frazier joined Merck in 1992 as vice president, general counsel. Prior to being appointed president, Mr Frazier served as executive vice president and president, Global Human Health, for three years.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts